Results 261 to 270 of about 135,898 (321)
Some of the next articles are maybe not open access.

Risk factors for bladder injury during placenta accreta spectrum surgery

International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 2022
To identify risk factors associated with bladder injury during placenta accreta spectrum (PAS) surgeries.
L. Friedrich   +8 more
semanticscholar   +1 more source

Placenta accreta spectrum: We can do better

Australian and New Zealand journal of obstetrics and gynaecology, 2022
Placenta accreta spectrum (PAS) has a high risk of maternal morbidity, and requires meticulous antenatal and peripartum management.
Cheryl Silveira   +3 more
semanticscholar   +1 more source

Systemic immune‐inflammation index to predict placenta accreta spectrum and its histological subtypes

The journal of obstetrics and gynaecology research, 2022
In this study, we aimed to investigate the role of systemic immune‐inflammation index (SII) and other inflammatory parameters in the diagnosis of placenta accreta spectrum (PAS) and its histological subtypes.
Ayşe Keleş   +6 more
semanticscholar   +1 more source

Overexpressed LAMC2 promotes trophoblast over‐invasion through the PI3K/Akt/MMP2/9 pathway in placenta accreta spectrum

The journal of obstetrics and gynaecology research, 2022
Placenta accreta spectrum (PAS) is an ongoing major iatrogenic public health challenge with devastating obstetric complications, but its underlying molecular pathogenesis remains poorly illuminated. LAMC2 is reported to regulate tumor cells proliferation
Runfang Wang   +6 more
semanticscholar   +1 more source

Prenatal diagnosis of placenta accreta spectrum

Current Opinion in Obstetrics and Gynecology, 2022
Purpose of review Placenta accreta spectrum (PAS) is a major cause of severe maternal morbidity. Perinatal outcomes are significantly improved when PAS is diagnosed prenatally. However, a large proportion of cases of PAS remain undiagnosed until delivery.
C. Conturie, D. Lyell
semanticscholar   +1 more source

Placenta Accreta and Percreta

Surgical Pathology Clinics, 2013
The incidence of abnormally adherent placenta (accreta/percreta) has increased 10-fold in the past 50 years, predominantly due to the increased use of cesarean section delivery. The causes, clinical correlates, and pathology of these conditions are discussed in this article.
openaire   +3 more sources

Placenta Praevia Accreta

Australian and New Zealand Journal of Obstetrics and Gynaecology, 1970
SummaryFive cases of placenta praevia accreta are reported. One patient was managed by total hysterectomy, and the other 4 by conservative measures. These cases bring the number reported to 100. The accretic process in placenta praevia was mainly the result of deficient decidual reaction in the lower segment; another common predisposing factor is the ...
openaire   +3 more sources

Red Blood Cell Transfusion in Patients With Placenta Accreta Spectrum

Obstetrics and Gynecology, 2022
At least 6 units of red blood cells should be available before patients with placenta accreta spectrum undergo delivery. OBJECTIVE: To evaluate red blood cell use during delivery in patients with placenta accreta spectrum.
Sarah E. Miller   +7 more
semanticscholar   +1 more source

Predicting Placenta Accreta Spectrum

Journal of Ultrasound in Medicine, 2020
ObjectivesThe placenta accreta spectrum (PAS) incidence has risen substantially over the past century, paralleling a rise in cesarean delivery (CD) rates. Prenatal diagnosis of PAS improves maternal outcomes. The Placenta Accreta Index (PAI) is a standardized approach to prenatal diagnosis of PAS incorporating clinical risk and ultrasound (US) findings
Sarah K. Happe   +8 more
openaire   +3 more sources

Risk Factors for Placenta Accreta

Obstetrics & Gynecology, 1999
To identify risk factors associated with placenta accreta in a large cohort study.Data for this study came from the Taiwan Down Syndrome Screening Group, an ongoing project on feasibility of serum screening in an Asian population. Women who had serum screening for Down syndrome at 14-22 weeks' gestation using alpha-fetoprotein (AFP) and free beta-hCG ...
Tsung-Hong Chiu   +9 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy